Search
Akari Therapeutics PLC
AKTXAdd to Watchlist
7.800USD
-0.200-2.50%
Close 07-31 16:00（ET）Quotes delayed by 15 min
8.93MMarket Cap
LossP/E TTM
AKTX Financials
See Akari Therapeutics PLC's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
Akari Therapeutics PLC Earnings Date
Latest Release
May 19, 2026
EPS / Forecast
-0.24/-1.38
Revenue / Forecast
--/0.00
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-0.52
99.22%
Analyst Rating
BUY
2026/07/31
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FAQs
What are the current assets of Akari Therapeutics PLC?
According to Akari Therapeutics PLC's FY2025 earnings report, its current assets were 5.46M, with a year-on-year change of 85.03.
What are the total assets of Akari Therapeutics PLC?
According to Akari Therapeutics PLC's FY2025 earnings report, its total assets of Akari Therapeutics PLC were 47.89M, with a year-on-year change of -5.28.
What are the total liabilities of Akari Therapeutics PLC?
According to Akari Therapeutics PLC's FY2025 earnings report, its total liabilities of Akari Therapeutics PLC were 19.56M, with a year-on-year change of -30.95.
What is the total equity of Akari Therapeutics PLC?
According to Akari Therapeutics PLC's FY2025 earnings report, its total equity of Akari Therapeutics PLC was 28.33M, with a year-on-year change of 27.44.
What is the net operating income of Akari Therapeutics PLC?
According to Akari Therapeutics PLC's FY2025 earnings report, its net operating income of Akari Therapeutics PLC was -17.27M, with a year-on-year change of 3.65.
What is the net financing of Akari Therapeutics PLC?
According to Akari Therapeutics PLC's FY2025 earnings report, its net financing of Akari Therapeutics PLC was 13.17M, with a year-on-year change of 19.87.
What is the Earnings Per Share (EPS) of Akari Therapeutics PLC?
According to Akari Therapeutics PLC's FY2025 earnings report, its Earnings Per Share (EPS) was -0.52, with a year-on-year change of 99.22.
What is the net income of Akari Therapeutics PLC?
According to Akari Therapeutics PLC's FY2025 earnings report, its net income was -17.30M, with a year-on-year change of 12.60.
What is the debt-to-asset ratio of Akari Therapeutics PLC?
According to Akari Therapeutics PLC's FY2025 earnings report, its debt-to-asset ratio was 1.57, with a year-on-year change of -75.58.
What is the Return on Equity (ROE) of Akari Therapeutics PLC?
According to Akari Therapeutics PLC's FY2025 earnings report, its Return on Equity (ROE) was -68.43, with a year-on-year change of 61.97.
What is the Return on Assets (ROA) of Akari Therapeutics PLC?
According to Akari Therapeutics PLC's FY2025 earnings report, its Return on Assets (ROA) was -35.14, with a year-on-year change of 51.25.
What is the operating profit of Akari Therapeutics PLC?
According to Akari Therapeutics PLC's FY2025 earnings report, its operating profit was -17.27M, with a year-on-year change of 3.65.